{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://xeltis.com/#organization",
      "name": "Xeltis",
      "url": "https://xeltis.com/",
      "description": "Home - Xeltis Skip to main content Search Close Search Menu Menu HOME Transformative vascular implants Addressing major life-threatening diseases, backed by Nobel-winning science Navigate to the next section aXess™ Living Access Starts Now aXess ™ is a medical device for patients requiring vascular access for hemodialysis. At implantation the patient’s own cells infiltrate the porous scaffold and begin early tissue integration. Post implantation aXess ™ is ready for cannulation after 14 days."
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/xeltis#asg",
      "name": "Xeltis ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/xeltis",
      "isPartOf": {
        "@id": "https://xeltis.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}